Brielle Benyon

Acupuncture reduced pain “in a very significant way” and urinary symptoms for patients with non-muscle invasive bladder cancer who were undergoing BCG therapy.

The third and final installment of the CURE® Open Mic Showcase features comedy, essay readings and videos from patients with cancer.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

The Food and Drug Administration granted a priority review for fruquintinib for patients with pretreated metastatic colorectal cancer.

Patients with cancer often experience loneliness, and the COVID-19 pandemic helped the general public better understand what that isolation felt like, an expert said.

This summer, a trial will kick off studying ISM3091 in patients with advanced solid tumors.

The second installment of CURE®’s Open Mic Showcase features cancer survivors performing original songs, showcasing a handmade deck of cards and reading poetry.

From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.

A telephone-based weight loss program proved to be efficacious in overweight or obese women with breast cancer and may lead to improved disease outcomes in the long run.

Research showed a survival improvement in adolescent and young adult cancer survival after the Dependent Care Expansion allowed patients to be on their parents’ insurance until the age of 26.

Hospice care can be a valuable resource for patients with late-stage cancer who want to improve the quality of the rest of their life.

The National Comprehensive Cancer Network updated its recommendations to include Krazati for patients with KRAS G12-mutant pancreatic cancer.

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced non-small cell lung cancer during the CURE® Educated Patient® Lung Cancer Summit.

The drug combination of Lonsurf plus Avastin improved survival in patients with pretreated, metastatic, refractory colorectal cancer, according to recently published study findings.

Watch Dr. Erminia Massarelli, from City of Hope National Medical Center, discuss advancements in early-stage non-small cell disease during the CURE® Educated Patient® Lung Cancer Summit.

Watch Dr. Ravi Salgia, from City of Hope, discuss advancements in small cell lung cancer during the CURE® Educated Patient® Lung Cancer Summit.

From music to poetry and dynamic storytelling, the first installment of CURE®’s Open Mic Showcase highlights the talents of patients and survivors of cancer.

From a teen cancer survivor being gifted tickets to Taylor Swift’s ‘Eras’ tour to Michael Hendry backing out of the US Open due to a leukemia diagnosis, here’s what’s happening in the oncology space this week.

Cryopreserved stem cells led to a higher rate of relapse in patients with blood cancer, though there was no difference in survival, research showed.

Palliative care — which focuses on quality of life — did not significantly improve outcomes in patients when delivered at the point of oncology surgery, highlighting the need to better understand when the best time to provide the service would be.

Acute myeloid leukemia and myelodysplastic syndrome may affect nutritional status, and more work is needed to ensure that patients are getting the food intake that they need, researchers found.

A recent review of research found that ginger is an effective non-drug way to manage chemotherapy-induced nausea and vomiting.

From Dolph Lundgren’s reveal of a years’-long experience with cancer to Jacklyn Zeman of “General Hospital” dying from the disease, here’s what’s happening in the oncology space this week.

In honor of mental health awareness month, we’re highlighting four blogs from cancer survivors about their emotional struggles and the methods they use to cope.

The recent FDA approval of Padcev plus Keytruda for locally advanced/metastatic, chemotherapy-ineligible bladder cancer offers an “exciting opportunity” for this difficult-to-treat patient population, an expert said.

The phase 3 HARMONi trial recently kicked off, studying ivonescimab plus chemotherapy for EGFR-mutant non-small cell lung cancer.

A clinical trial studying an accelerated dose of Besremi recently kicked off.

A small survey of women with head and neck cancer found that while many experience physical and emotional distress, social supports can help.

As more personalized treatments become available in the ovarian cancer space, tumor testing, such as next-generation sequencing, may play a bigger role.

Men with low-risk prostate cancer can usually safely forego treatment as long as they continue to monitor their disease with their clinicians, an expert said.